FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to oncology, and can be used to predict three-month survival in patients with stage IV pancreatic cancer using photodynamic therapy. For this purpose, the level of fibrinogen is determined in patients before the start of treatment. The level of fibrinogen above 3.40 g/l makes it possible to predict a decrease in the probability of three-month survival in patients with malignant neoplasm of the pancreas when using photodynamic therapy.
EFFECT: invention allows to predict three-month survival rate in patients with stage IV pancreatic malignancy with high reliability, sensitivity and specificity.
1 cl, 2 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR INTRAOPERATIVE PREVENTION OF LYMPHORRHEA WHEN PERFORMING RADICAL MASTECTOMY OR RADICAL RESECTION OF MAMMARY GLAND WITH AXILLARY-SUBCLAVIAN-SUBCLAVIAN LYMPH NODE DISSECTION | 2023 |
|
RU2818949C1 |
| METHOD OF COMBINED TREATMENT OF UNRESECTABLE CANCER OF EXTRAHEPINOUS BILE DUCTS | 2018 |
|
RU2703330C2 |
| METHOD FOR STEREOTACTIC RADIATION THERAPY OF PATIENTS WITH LOCAL RELAPSE OF PROSTATE CANCER AFTER LOW-POWER BRACHYTHERAPY | 2022 |
|
RU2793064C1 |
| METHOD FOR ASSESSING RISK OF PROGRESSION OF METASTATIC COLORECTAL CANCER AFTER ANTI-VEGF THERAPY | 2024 |
|
RU2823505C1 |
| METHOD FOR DETERMINING INDICATIONS FOR REMOVAL OF PRIMARY TUMOUR IN PATIENT WITH SYNCHRONOUS DISTANT METASTASES OF COLORECTAL CANCER IN PRESENCE OF INTESTINAL OBSTRUCTION | 2023 |
|
RU2818550C1 |
| METHOD FOR PREDICTING RECURRENCE OF NON-MUSCLE INVASIVE BLADDER CANCER | 2022 |
|
RU2793510C1 |
| METHOD OF PREDICTING HEMATOGENOUS METASTASIS OF COLON CANCER AFTER COMBINED TREATMENT | 2023 |
|
RU2797845C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING BREAST CANCER IN WOMEN BASED ON DATA ON INTERLOCUS INTERACTIONS | 2023 |
|
RU2815932C1 |
| METHOD FOR EARLY DETECTION OF MALIGNANT NEOPLASMS OF PANCREAS IN PATIENTS WITH NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS | 2023 |
|
RU2822658C1 |
| METHOD FOR ADJUVANT RADIOTHERAPY IN PATIENTS WITH PROSTATE CANCER METASTASES IN REGIONAL PELVIC LYMPH NODES AFTER RADICAL PROSTATECTOMY | 2022 |
|
RU2787556C1 |
